How I treat acute lymphocytic leukemia in adultsROWE, Jacob M; GOLDSTONE, Anthony H.Blood. 2007, Vol 110, Num 7, pp 2268-2275, issn 0006-4971, 8 p.Article

Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working PartyWHEATLEY, Keith; GOLDSTONE, Anthony H; LITTLEWOOD, Tim et al.British journal of haematology. 2009, Vol 146, Num 1, pp 54-63, issn 0007-1048, 10 p.Article

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignanciesEYRE, Toby A; COLLINS, Graham P; GOLDSTONE, Anthony H et al.British journal of haematology. 2014, Vol 166, Num 3, pp 336-351, issn 0007-1048, 16 p.Article

Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationKYRIAKOU, Charalampia; CANALS, Carmen; FINKE, Jürgen et al.Journal of clinical oncology. 2009, Vol 27, Num 24, pp 3951-3958, issn 0732-183X, 8 p.Article

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsWHEATLEY, Keith; BROOKES, Cassandra L; HOWMAN, Andrew J et al.British journal of haematology. 2009, Vol 145, Num 5, pp 598-605, issn 0007-1048, 8 p.Article

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients : final results of the International ALL Trial (MRC UKALL XD/ECOG E2993)GOLDSTONE, Anthony H; RICHARDS, Susan M; PAIETTA, Elisabeth et al.Blood. 2008, Vol 111, Num 4, pp 1827-1833, issn 0006-4971, 7 p.Article

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaHARRISON, Christine J; MOORMAN, Anthony V; EDEN, Tim O. B et al.British journal of haematology. 2004, Vol 125, Num 5, pp 552-559, issn 0007-1048, 8 p.Article

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disordersPEREZ-SIMON, José A; KOTTARIDIS, Panagiotis D; PARKER, Anne et al.Blood. 2002, Vol 100, Num 9, pp 3121-3127, issn 0006-4971, 7 p.Article

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy : analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trialsKOTTARIDIS, Panagiotis D; GALE, Rosemary E; GOLDSTONE, Anthony H et al.Blood. 2001, Vol 98, Num 6, pp 1752-1759, issn 0006-4971Article

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationKOTTARIDIS, Panagiotis D; MILLIGAN, Donald W; SCHEY, Stephen et al.Blood. 2000, Vol 96, Num 7, pp 2419-2425, issn 0006-4971Article

Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell―Depleted Allogeneic Transplantation for Hodgkin's LymphomaPEGGS, Karl S; KAYANI, Irfan; THOMSON, Kirsty J et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 971-978, issn 0732-183X, 8 p.Article

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%MOHAMEDBHAI, Sajir G; SIBSON, Keith; MARAFIOTI, Teresa et al.British journal of haematology. 2011, Vol 152, Num 2, pp 175-181, issn 0007-1048, 7 p.Article

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPABURNETT, Alan K; HILLS, Robert K; PRENTICE, Archibald G et al.Blood. 2010, Vol 115, Num 5, pp 948-956, issn 0006-4971, 9 p.Article

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatmentBURNETT, Alan K; MILLIGAN, Donald; PRENTICE, Archie G et al.Cancer. 2007, Vol 109, Num 6, pp 1114-1124, issn 0008-543X, 11 p.Article

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL) : analysis of cytogenetic data from patients treated on the medical research council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. CommentaryAPPELBAUM, Frederick R; MOORMAN, Anthony V; FIELDING, Adele K et al.Blood. 2007, Vol 109, Num 8, issn 0006-4971, 3127,3189-3197 [10 p.]Article

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis : results from the international ALL trial MRC UKALL XII/ECOG E2993LAZARUS, Hillard M; RICHARDS, Susan M; DURRANT, I. Jill et al.Blood. 2006, Vol 108, Num 2, pp 465-472, issn 0006-4971, 8 p.Article

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. CommentaryCORRADINI, Paolo; FARINA, Lucia; DOGAN, Ahmet et al.Lancet (British edition). 2005, Vol 365, Num 9475, pp 1906-1908, issn 0140-6736, 11 p.Article

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposureKOTHARI, Jaimal; PEGGS, Karl S; BIRD, Antonia et al.British journal of haematology. 2014, Vol 165, Num 3, pp 334-340, issn 0007-1048, 7 p.Article

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 TrialBURNETT, Alan K; HILLS, Robert K; MILLIGAN, Donald et al.Journal of clinical oncology. 2011, Vol 29, Num 4, pp 369-377, issn 0732-183X, 9 p.Article

Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 TrialBURNETT, Alan K; HILLS, Robert K; MILLIGAN, Donald W et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 586-595, issn 0732-183X, 10 p.Article

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993PATEL, Bella; RAI, Lena; FIELDING, Adele K et al.British journal of haematology. 2010, Vol 148, Num 1, pp 80-89, issn 0007-1048, 10 p.Article

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsGRIMWADE, David; HILLS, Robert K; MOORMAN, Anthony V et al.Blood. 2010, Vol 116, Num 3, pp 354-365, issn 0006-4971, 12 p.Article

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionPATEL, Bella; KIRKLAND, Keiren E; POTTER, Mike N et al.Haematologica (Roma). 2009, Vol 94, Num 10, pp 1399-1406, issn 0390-6078, 8 p.Article

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trialSCHMITZ, Norbert; PFISTNER, Beate; LOHRI, Andreas et al.Lancet (British edition). 2002, Vol 359, Num 9323, pp 2065-2071, issn 0140-6736Article

IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor OutcomeRUSSELL, Lisa J; ENSHAEI, Amir; MITCHELL, Christopher D et al.Journal of clinical oncology. 2014, Vol 32, Num 14, pp 1453-1462, issn 0732-183X, 10 p.Article